Exploration of neoadjuvant chemotherapy and post-tumor microenvironment for advanced gastric cancer (GC) or gastroesophageal junction cancer (EGJ)

被引:0
|
作者
Gou, Miaomiao
Gao, Yunhe
Qiao, Zhi
Wang, Zhi-Kuan
Liu, Yi
Dai, Guanghai
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Peoples Liberat Army Gen Hosp, Senior Dept Oncol, Med Ctr 5, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16099
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Total neoadjuvant chemotherapy with FOLFIRINOX regimen in patients with resectable locally advanced gastric and gastroesophageal junction cancer
    Sedova, M. V.
    Batov, M. A.
    Kolomeytseva, A. A.
    Khomyakov, V. M.
    Volchenko, N. N.
    Fedenko, A. A.
    Kaprin, A. D.
    ANNALS OF ONCOLOGY, 2023, 34 : S881 - S881
  • [2] Locally advanced gastroesophageal junction cancer: Neoadjuvant treatment with VMAT and concomitant chemotherapy
    Tozzi, A.
    Iftode, C.
    Comito, T.
    Campisi, M. C.
    Navarria, P.
    Clerici, E.
    Maggi, G.
    Mancosu, P.
    Stravato, A.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S69 - S69
  • [3] Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer
    Soto, Maira
    Filbert, Erin L.
    Yang, Hai
    Starzinski, Stephanie
    Starzinski, Alec
    Gin, Marissa
    Chen, Brandon
    Le, Phi
    Li, Tony
    Bol, Brandon
    Cheung, Alexander
    Zhang, Li
    Hsu, Frank J.
    Ko, Andrew
    Fong, Lawrence
    Keenan, Bridget P.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 200 - 212
  • [4] Tumor regression and nodal status to neoadjuvant chemotherapy as a prognostic marker in patients with locally advanced gastric and gastroesophageal cancer
    Marcisz-Grzanka, K.
    Rybski, S.
    Siwik, M.
    Sulkowska, U.
    Wyrwicz, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S134 - S134
  • [5] Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction A Meta-Analysis
    Jiang, Lei
    Yang, Ke-hu
    Guan, Quan-lin
    Chen, Yan
    Zhao, Peng
    Tian, Jin-hui
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (05) : 387 - 394
  • [6] Envafolimab plus chemotherapy in advanced gastric or gastroesophageal junction (G/GEJ) cancer.
    Yin, Xianli
    Zhang, Yun
    Deng, Yanhong
    Xu, Nong
    Xu, Jianming
    Li, Lei
    Song, Xiaotong
    Lu, Haolan
    Gong, John
    Liu, Dongfang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
    Paszt, Attila
    Simonka, Zsolt
    Budai, Krisztina
    Horvath, Zoltan
    Erdos, Marton
    Vas, Marton
    Ottlakan, Aurel
    Nyari, Tibor
    Szepes, Zoltan
    Uhercsak, Gabriella
    Maraz, Aniko
    Torday, Laszlo
    Tiszlavicz, Laszlo
    Olah, Judit
    Lazar, Gyorgy
    FRONTIERS IN SURGERY, 2023, 10
  • [8] Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
    Paschold, Lisa
    Binder, Mascha
    CURRENT ONCOLOGY, 2022, 29 (03) : 1430 - 1441
  • [9] THE EFFECTS OF NEOADJUVANT CHEMOTHERAPY ON THE TUMOR MICROENVIRONMENT IN CERVICAL CANCER
    Heeren, M.
    van Luijk, I.
    Lakeman, J.
    Pocorni, N.
    Kole, J.
    de Kroon, C.
    de Gruijl, T.
    Kenter, G.
    Bosse, T.
    Jordanova, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 149 - 149
  • [10] Perioperative chemotherapy for gastric and gastroesophageal junction cancer, European perspective
    Smyth, E. C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1299 - S1299